bit.bio has secured $25 million (£19m) in Series D funding as demand for its human cell models reaches record levels. The Cambridge BioTech is aiming to become the world’s leading supplier of human cells for life sciences research. It said paid vial volumes have increased 76% in 2026.  Orders are up 34% and active customers … Continue reading Human cell manufacturer bit.bio wins £19m backing